Table 2.
Cancer type | Animal models | Concn. | Administration | Duration | Suggested mechanism | Ref. |
---|---|---|---|---|---|---|
Hepatoma | HSVtk/Hep3B cells xenograft tumour in nude mice | 10 mg/kg | Intraperitoneal injection | Every other day for 33 days | Inhibition of growth. Promotion of apoptosis. Chemosensitization (HSVtk/GCV) | (Zhang et al. 2019) |
Lung cancer | HCC827/GR cells xenograft tumour in nude mice | 5, 10 mg/kg | Not mentioned | Every day for 14 days | Inhibition of growth. Promotion of apoptosis. Chemosensitization (gefitinib) | (Tang et al. 2019) |
Breast cancer | MCF-7/ADR cells xenograft tumour in nude mice | 5 mg/kg | Intraperitoneal injection | Every other day for 20 days | Inhibition of growth. Inhibition of P-gp expression. Reversal of MDR without toxic effect. | (Li, Xue et al. 2017) |
Thyroid carcinoma | ARO cells xenograft tumour in nude mice | 5–20 mg/kg | Oral gavage | Every day for 4 weeks | Inhibition of growth. | (Liu and Li 2014) |